@article{3053417,
    title = "Scintimammographic findings of in situ ductal breast carcinoma in a
double-phase study with Tc-99m(V) DMSA and Tc-99m MIBI value of
Tc-99m(V) DMSA",
    author = "Papantoniou, V and Sotiropoulou, M and Stipsaneli, E and Louvrou, A and and Feda, H and Christodoulidou, J and Pampouras, G and Zerva, C and and Keramopoulos, A and Michalas, S",
    journal = "Clinical Nuclear Medicine",
    year = "2000",
    volume = "25",
    number = "6",
    pages = "434-439",
    publisher = "Lippincott, Williams & Wilkins",
    issn = "0363-9762, 1536-0229",
    doi = "10.1097/00003072-200006000-00009",
    keywords = "in situ ductal breast carcinoma; Tc-99m(V) DMSA; Tc-99m MIBI",
    abstract = "The authors present a case of in situ ductal carcinoma of the breast
(DCIS) with no associated mass in a 46-year-old woman examined with
Tc-99m MIBI and Tc-99m(V) DMSA scans, which were acquired in separate
sessions 10 minutes and 60 minutes after injection. Histologic analysis
revealed a small (<1 cm) infiltrating ductal carcinoma located within
the DCIS. Mammography showed a cluster of microcalcifications on a very
dense parenchymal background. Tc-99m(V) DMSA was characterized as
positive for DCIS, especially in the delayed image. Tc-99m MIBI failed
to identify the lesions previously noted. In conclusion, Tc-99m(V) DMSA
scintimammography seems to have an advantage and could improve the
detection of nonpalpable in situ breast carcinomas."
}